Sassmannshausen J, Bornfeld N, Foerster M H, Sauerwein W, Schreiber T, Wessing A
Augenklinik, Universität (GHS) Essen.
Fortschr Ophthalmol. 1990;87(1):69-73.
A total of 161 cases of choroidal metastases are reviewed. Breast or bronchial carcinomas are the most frequent primary tumors. One-third of the patients develop bilateral choroidal metastases. In 67% of all cases metastatic choroidal lesions were found in the posterior pole. Eighty-nine percent of all patients had a history of malignant tumor, in 11% of all patients choroidal metastasis was the first sign of a primary carcinoma elsewhere in the body. Sixty percent of all patients with choroidal metastases had additional other distant metastases at the time of diagnosis of choroidal involvement. The survival rate is poor: 50% of all patients with choroidal metastasis had died 1 year later. In 35% of all patients, choroidal metastases occurred despite prior systemic therapy with cytotoxic drugs or hormone therapy. In many cases the spontaneously course leads to irreversible loss of central visual acuity due to tumor growth, tumor necrosis or the complications of an exudative retinal detachment. Early fractionated external beam in radiation may prevent this outcome. The clinical course in 71 eyes following irradiation is reported. In 80% radiation therapy led to regression or eradication of the tumor, and a vision of at least 0.4 was maintained in 61% of the treated eyes.
回顾了总共161例脉络膜转移瘤病例。乳腺癌或支气管癌是最常见的原发肿瘤。三分之一的患者发生双侧脉络膜转移。在所有病例中,67%的转移性脉络膜病变位于后极部。89%的患者有恶性肿瘤病史,11%的患者脉络膜转移是身体其他部位原发性癌的首发症状。60%的脉络膜转移患者在诊断脉络膜受累时还伴有其他远处转移。生存率很低:50%的脉络膜转移患者在1年后死亡。35%的患者尽管之前接受了细胞毒性药物全身治疗或激素治疗,仍发生了脉络膜转移。在许多情况下,由于肿瘤生长、肿瘤坏死或渗出性视网膜脱离的并发症,自然病程会导致中心视力不可逆转的丧失。早期分次外照射可能会避免这种结果。报告了71只眼照射后的临床病程。80%的放射治疗导致肿瘤消退或根除,61%的治疗眼维持了至少0.4的视力。